SCHEMBL1636596

SCHEMBL1636596

Cc1ccc(-c2cccc(Cl)n2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 6/20 0.52
KMT2A Q03164 6/20 0.52
ALDH1A1 P00352 6/20 0.52
KDM4E B2RXH2 3/20 0.52
MAPT P10636 2/20 0.52
HPGD P15428 2/20 0.52
L3MBTL1 Q9Y468 2/20 0.52
TDP1 Q9NUW8 1/20 0.52
JAK2 O60674 1/20 0.45
POLB P06746 1/20 0.43
HSD17B10 Q99714 1/20 0.43
RAB9A P51151 3/20 0.43
ENPP3 O14638 1/20 0.41
ENPP1 P22413 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
SREBF2 Q12772 1/20 0.41
NPC1 O15118 2/20 0.40
HSD11B1 P28845 1/20 0.40
MITF O75030 1/20 0.40
KDM5A P29375 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3421833 0.84 KMT2A (0.59) MEN1KMT2AALDH1A1KDM4EMAPT
SCHEMBL23921025 0.82 KMT2A (0.56) MEN1KMT2AALDH1A1KDM4EMAPT
SCHEMBL4401760 0.82 KMT2A (0.56) MEN1KMT2AALDH1A1KDM4EMAPT
SCHEMBL1662450 0.80 MEN1 (0.68) MEN1KMT2AALDH1A1KDM4EMAPT
SCHEMBL13689657 0.80 KMO (0.47) KDM4EJAK2RAB9AENPP3NPC1
SCHEMBL27832833 0.79 MAPT (0.72) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL30424039 0.79 JAK2 (0.45) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL24253527 0.79 JAK2 (0.45) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL29802659 0.79 JAK2 (0.42) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL23093234 0.79 JAK2 (0.42) MEN1KMT2AALDH1A1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1724263-B1 BASIC AMINE COMPOUND AND USE THEREOF KUREHA CORP (JP) 2014-03-05 EP disclosed
US-20110172212-A1 AMINE-BASED COMPOUND AND USE THEREOF KUREHA CORPORATION (JP) 2011-07-14 US disclosed
US-7932281-B2 Amine-based compound and use thereof KUREHA CORPORATION (JP) 2011-04-26 US disclosed
US-20070208007-A1 Amine-Based Compound and Use Thereof KUREHA CORPORATION (JP) 2007-09-06 US disclosed
EP-1724263-A1 BASIC AMINE COMPOUND AND USE THEREOF Kureha Corporation (JP) 2006-11-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110172212-A1 AMINE-BASED COMPOUND AND USE THEREOF NR0B2, NR5A2, NR1D2 MEN1 1008/4885KMT2A 474/4885ALDH1A1 2045/4885
US-20070208007-A1 Amine-Based Compound and Use Thereof NR0B2, NR5A2, NR2E1 MEN1 1361/4885KMT2A 488/4885ALDH1A1 1901/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.